Loading company…
Rellergen develops microfluidic diagnostic products for allergy and autoimmune diseases.
Founded in 2016 and based in Xiamen, China, Rellergen develops microfluidic chip testing technology for allergy and autoimmune disease diagnostics. Its platform combines microfluidics, protein coating, and chemiluminescence detection, including allergen sIgE testing. The company completed tens of millions yuan in Pre-A round financing.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in